Fig. 3

Response rates at week 4, week 8, and week 12 in the global patients’ population (ALL), patients with high-frequency episodic migraine (HFEM), and chronic migraine (CM)
Response rates at week 4, week 8, and week 12 in the global patients’ population (ALL), patients with high-frequency episodic migraine (HFEM), and chronic migraine (CM)